Valuation GlaxoSmithKline S.A.E

Stocks

End-of-day quote Egyptian Exchange 2026-08-30			5-day change	1st Jan Change
413.02 ^EGP	-7.19%		-15.25%	+548.89%

08-13	GlaxoSmithKline S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-17	GlaxoSmithKline Q1 consol net profit EGP 4.7 million	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	1,416	2,579	3,187	2,969	3,007	5,316
Change	-	82.08%	23.58%	-6.84%	1.27%	76.81%
Enterprise Value (EV) ¹	1,540	2,685	2,671	2,237	3,051	4,918
Change	-	74.37%	-0.55%	-16.25%	36.39%	61.21%
P/E	50.4x	16.7x	4.33x	49.1x	17.3x	24.9x
PBR	1.17x	1.9x	1.84x	1.51x	1.51x	2.4x
PEG	-	0x	0x	-0.5x	0x	1.1x
Capitalization / Revenue	0.71x	1.42x	1.75x	1.33x	1.01x	1.42x
EV / Revenue	0.77x	1.48x	1.46x	1x	1.02x	1.32x
EV / EBITDA	6.67x	9.65x	55x	4.7x	6.55x	18.5x
EV / EBIT	7.6x	11.1x	174x	5.07x	7.16x	22.7x
EV / FCF	16.1x	54.1x	24.6x	12.8x	-5.83x	15.4x
FCF Yield	6.22%	1.85%	4.06%	7.79%	-17.1%	6.5%
Dividend per Share ²	-	0.75	-	0.75	1	0.75
Rate of return	-	2.43%	-	2.11%	2.78%	1.18%
EPS ²	0.3368	1.852	8.805	0.7239	2.083	2.553
Distribution rate	-	40.5%	-	104%	48%	29.4%
Net sales ¹	1,993	1,812	1,823	2,240	2,991	3,731
EBITDA ¹	230.9	278.3	48.6	475.6	465.8	265.1
EBIT ¹	202.5	242.2	15.33	441.5	425.9	216.6
Net income ¹	28.13	154.6	735.4	60.46	174	213.2
Net Debt ¹	123.6	106.4	-516.3	-732.3	44.01	-397.9
Reference price ²	16.96	30.88	38.16	35.55	36.00	63.65
Nbr of stocks (in thousands)	83,514	83,514	83,514	83,514	83,514	83,514
Announcement Date	5/30/22	5/30/22	3/18/24	3/18/24	3/9/25	3/12/26

¹EGP in Million²EGP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE S.A.E	-	-	-	-	686M
ELI LILLY AND COMPANY	33.44x	12.14x	24.6x	0.59%	1,047B
JOHNSON & JOHNSON	29.82x	-	-	2%	646B
ABBVIE INC.	32.61x	7.57x	15.74x	2.68%	451B
ROCHE HOLDING AG	19.99x	4.75x	11.76x	2.79%	355B
NOVARTIS AG	21.76x	5.62x	13.93x	2.85%	291B
ASTRAZENECA PLC	20.88x	4.29x	12.24x	2.06%	252B
AMGEN INC.	27.35x	7.07x	12.56x	2.33%	234B
NOVO NORDISK A/S	13.25x	4.77x	9.95x	3.83%	203B
GILEAD SCIENCES, INC.	-44.51x	6.43x	25.11x	2.26%	181B
Average	17.17x	6.58x	15.74x	2.38%	366B
Weighted average by Cap.	24.24x	8.07x	17.81x	1.97%